BIANCA WHITLOW: Open Payments
NPI 1316643000 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,018 in 186 payments from 21 companies in 2025. Trend: 2023 $556 · 2024 $2,035 · 2025 $4,018
Food & beverage: $4,018
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 46 | $1,130 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 21 | $448 |
| Phathom Pharmaceuticals, Inc. | 21 | $438 |
| Madrigal Pharmaceuticals | 13 | $275 |
| GENZYME CORPORATION | 11 | $255 |
| QOL Medical, LLC | 9 | $248 |
| Regeneron Healthcare Solutions, Inc. | 11 | $240 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $201 |
| Lilly USA, LLC | 10 | $177 |
| Ardelyx, Inc. | 10 | $155 |
Products named: DUPIXENT, RINVOQ, VOQUEZNA, XIFAXAN, REZDIFFRA, Sucraid, LINZESS, OMVOH.
Industry payments across KY — which companies pay providers there.
